Scarica l'app Stockscreener
2.34
1.30%
0.03
Dopo l'orario di chiusura:
2.49
0.15
+6.41%
Precedente Chiudi:
$2.31
Aprire:
$2.31
Volume 24 ore:
49,559
Relative Volume:
0.39
Capitalizzazione di mercato:
$234.96M
Reddito:
-
Utile/perdita netta:
$-60.14M
Rapporto P/E:
-3.2981
EPS:
-0.7095
Flusso di cassa netto:
$-68.17M
1 W Prestazione:
+13.59%
1M Prestazione:
+27.87%
6M Prestazione:
-13.33%
1 anno Prestazione:
-36.59%
Intervallo 1D:
$2.28
$2.3726
Intervallo di 1 settimana:
$2.02
$2.3726
Portata 52W:
$1.4299
$4.26
Ac Immune Sa Stock (ACIU) Company Profile
Confronta ACIU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.34 | 232.39M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-31 | Iniziato | BTIG Research | Buy |
| 2019-02-01 | Downgrade | UBS | Buy → Neutral |
| 2019-01-04 | Iniziato | UBS | Buy |
| 2018-04-05 | Iniziato | H.C. Wainwright | Buy |
| 2018-03-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | Iniziato | Credit Suisse | Outperform |
| 2016-10-18 | Iniziato | Jefferies | Buy |
| 2016-10-18 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Ac Immune Sa Borsa (ACIU) Ultime notizie
Published on: 2025-07-23 19:50:12 - jammulinksnews.com
What drives AC Immune SA stock priceConsistent triple-digit returns - Autocar Professional
What analysts say about AC Immune SA stockUnprecedented growth rates - Autocar Professional
Is AC Immune SA a good long term investmentConsistently profitable trades - jammulinksnews.com
AC Immune SA Stock Analysis and ForecastExceptional risk-adjusted gains - jammulinksnews.com
AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech
How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser
Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser
What makes AC Immune SA stock price move sharplyFree Access to Community - Newser
Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune SA Announces Executive Changes - MarketScreener
AC Immune SA Announces Leadership Changes in Development Team - TipRanks
AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st
Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World
Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World
Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World
June 2025 Penny Stocks With Promising Potential - simplywall.st
Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World
Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com
Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World
Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st
TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient
Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN
AC Immune (ACIU) to Release Earnings on Monday - Defense World
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune (NASDAQ:ACIU) Downgraded by StockNews.com to “Hold” - Defense World
Ac Immune Sa Azioni (ACIU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):